Dimensional Fund Advisors’s BioAtla BCAB Stock Holding History

Dimensional Fund Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,779	Closed	-$52.6K	–	3330
2024 Q4	$52.6K	Sell	1,779 -1,725	-49%	-$145K	﹤0.01%	3285
2024 Q3	$307K	Sell	3,504 -3,173	-48%	-$266K	﹤0.01%	3107
2024 Q2	$458K	Buy	6,677 +1,472	+28%	+$175K	﹤0.01%	3041
2024 Q1	$895K	Buy	5,205 +990	+23%	+$123K	﹤0.01%	2942
2023 Q4	$518K	Sell	4,215 -969	-19%	-$84K	﹤0.01%	3040
2023 Q3	$441K	Buy	5,184 +4,545	+711%	+$579K	﹤0.01%	3069
2023 Q2	$95.8K	Sell	639 -281	-31%	-$48.3K	﹤0.01%	3330
2023 Q1	$123K	Buy	920 +20	+2%	+$3.6K	﹤0.01%	3279
2022 Q4	$371	Buy	900 +363	+68%	+$151K	﹤0.01%	3095
2022 Q3	$207K	Buy	+537	New	+$176K	﹤0.01%	3230

Other funds holding BCAB

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Dimensional Fund Advisors's BCAB Position: Q1 2025 in Review

Dimensional Fund Advisors sold out of BioAtla (BCAB) in Q1 2025, closing a stake of 1,779 shares — an estimated $52.6K sold.

Dimensional Fund Advisors first reported a position in BCAB in Q3 2022 and held it in 10 quarters. The position peaked at $895K in Q1 2024. 41 funds tracked by Wall St. Rank hold BCAB as of Q1 2025.

Dimensional Fund Advisors reported no remaining BioAtla position as of Q1 2025 after selling out during the quarter.
Dimensional Fund Advisors sold 1,779 BioAtla shares in Q1 2025, an estimated $52.6K.
Dimensional Fund Advisors first reported a position in BioAtla in Q3 2022 and held it in 10 quarters.
Dimensional Fund Advisors's BioAtla position peaked at $895K in Q1 2024.
41 funds tracked by Wall St. Rank held BioAtla as of Q1 2025.

Based on Dimensional Fund Advisors's 13F filing for Q1 2025, filed 13 May 2025.